Evaluation of Safety Profiles of Blood Cancer Drugs Approved in Japan

被引:0
|
作者
Sachie Kubota
Kazuyuki Saito
Shunsuke Ono
Yasuo Kodama
机构
[1] Josai International University,Laboratory of Pharmaceutical Regulatory Science, Graduate School of Pharmaceutical Sciences
[2] National Center for Child Health and Development,Department of Development Strategy
[3] The University of Tokyo,Laboratory of Pharmaceutical Regulatory Science, Graduate School of Pharmaceutical Sciences
关键词
safety profile; anticancer drug; NOAEL; clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:228 / 235
页数:7
相关论文
共 50 条
  • [1] Evaluation of Safety Profiles of Blood Cancer Drugs Approved in Japan
    Kubota, Sachie
    Saito, Kazuyuki
    Ono, Shunsuke
    Kodama, Yasuo
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (02) : 228 - 235
  • [2] Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan
    Kubota, Sachie
    Saito, Kazuyuki
    Ono, Shunsuke
    Kodama, Yasuo
    [J]. DRUGS IN R&D, 2017, 17 (01) : 133 - 143
  • [3] Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan
    Sachie Kubota
    Kazuyuki Saito
    Shunsuke Ono
    Yasuo Kodama
    [J]. Drugs in R&D, 2017, 17 : 133 - 143
  • [4] Safety Profiles and Pharmacovigilance Considerations for Recently Patented / Approved Anticancer Drugs
    Baldo, Paolo
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2019, 14 (03) : 202 - 202
  • [5] Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan
    Bun, Seiko
    Yonemori, Kan
    Sunadoi, Hiroko
    Nishigaki, Rena
    Noguchi, Emi
    Okusaka, Takuji
    Nishida, Toshirou
    Fujiwara, Yasuhiro
    [J]. JCO ONCOLOGY PRACTICE, 2021, 17 (03) : 148 - +
  • [6] Postmarket safety communications on drugs approved in Japan: A 25-year analysis
    Tanaka, Yusuke
    Tanaka, Mototsugu
    Miyazawa, Haruna
    Terashima, Ryohei
    Miyazawa, Makoto
    Ikuma, Mutsuhiro
    Tomita, Yoshihiko
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [8] Safety of newly approved drugs questioned
    不详
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (12) : 1147 - 1147
  • [9] Lifecycle management of orphan drugs approved in Japan
    Kiyoshi Seki
    Hiroshi Suzuki
    Seiji Abe
    Chikako Saotome
    [J]. Orphanet Journal of Rare Diseases, 17
  • [10] Lifecycle management of orphan drugs approved in Japan
    Seki, Kiyoshi
    Suzuki, Hiroshi
    Abe, Seiji
    Saotome, Chikako
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)